Bayer Ag Popular Books

Bayer Ag Biography & Facts

Bayer AG (, commonly pronounced ; German: [ˈbaɪɐ]) is a German multinational pharmaceutical and biotechnology company and is one of the largest pharmaceutical companies and biomedical companies in the world. Headquartered in Leverkusen, Bayer's areas of business include: pharmaceuticals, consumer healthcare products, agricultural chemicals, seeds and biotechnology products. The company is a component of the EURO STOXX 50 stock market index. Bayer was founded in 1863 in Barmen as a partnership between dye salesman Friedrich Bayer (1825–1880) and dyer Friedrich Weskott (1821–1876). The company was established as a dyestuffs producer, but the versatility of aniline chemistry led Bayer to expand its business into other areas. In 1899, Bayer launched the compound acetylsalicylic acid under the trademarked name Aspirin. Aspirin is on the World Health Organization's List of Essential Medicines. In 2021, it was the 34th most commonly prescribed medication in the United States, with more than 17 million prescriptions. In 1904, Bayer received a trademark for the "Bayer Cross" logo, which was subsequently stamped onto each aspirin tablet, creating an iconic product that is still sold by Bayer. Other commonly known products initially commercialized by Bayer include heroin, phenobarbital, polyurethanes, and polycarbonates. In 1925, Bayer merged with five other German companies to form IG Farben, creating the world's largest chemical and pharmaceutical company. The first sulfonamide and the first systemically active antibacterial drug, forerunner of antibiotics, Prontosil, was developed by a research team led by Gerhard Domagk in 1932 or 1933 at the Bayer Laboratories. Following World War II, the Allied Control Council seized IG Farben's assets because of its role in the Nazi war effort and involvement in the Holocaust, including using slave labour from concentration camps and humans for dangerous medical testing, and production of Zyklon B, a chemical used in gas chambers. In 1951, IG Farben was split into its constituent companies, and Bayer was reincorporated as Farbenfabriken Bayer AG. Bayer played a key role in the Wirtschaftswunder in post-war West Germany, quickly regaining its position as one of the world's largest chemical and pharmaceutical corporations. In 2016, Bayer merged with the American multinational Monsanto in what was the biggest acquisition by a German company to date. However, owing to the massive financial and reputational blows caused by ongoing litigation concerning Monsanto's herbicide Roundup, the deal is considered one of the worst corporate mergers in history. Bayer owns the Bundesliga football club Bayer 04 Leverkusen. Early history Foundation Bayer AG was founded as a dyestuffs factory in 1863 in Barmen (later part of Wuppertal), Germany, by Friedrich Bayer and his partner, Johann Friedrich Weskott, a master dyer. Bayer was responsible for the commercial tasks. Fuchsine and aniline became the company's most important products. The headquarters and most production facilities moved from Barmen to a larger area in Elberfeld in 1866. Friedrich Bayer (1851–1920), the son of the company's founder, was a chemist and joined the company in 1873. After the death of his father in 1880, the company became a joint-stock company, Farbenfabriken vorm. Friedr. Bayer & Co, also known as Elberfelder Farbenfabriken. A further expansion in Elberfeld was impossible, so the company moved to the village Wiesdorf at Rhein and settled in the area of the alizarin producer Leverkus and Sons. A new city, Leverkusen, was founded there in 1930 and became home to Bayer AG's headquarters. The company's corporate logo, the Bayer cross, was introduced in 1904, consisting of the word BAYER written vertically and horizontally, sharing the Y and enclosed in a circle. An illuminated version of the logo is a landmark in Leverkusen. Aspirin Bayer's first major product was acetylsalicylic acid—first described by French chemist Charles Frederic Gerhardt in 1853—a modification of salicylic acid or salicin, a folk remedy found in the bark of the willow plant. By 1899, Bayer's trademark Aspirin was registered worldwide for Bayer's brand of acetylsalicylic acid, but it lost its trademark status in the United States, France and the United Kingdom after the confiscation of Bayer's US assets and trademarks during World War I by the United States, and because of the subsequent widespread usage of the word. The term aspirin continued to be used in the US, UK and France for all brands of the drug, but it is still a registered trademark of Bayer in over 80 countries, including Canada, Mexico, Germany and Switzerland. As of 2011, approximately 40,000 tons of aspirin were produced each year and 10–20 billion tablets consumed in the United States alone for prevention of cardiovascular events. It is on the WHO Model List of Essential Medicines, the most important medications needed in a basic health system. There is an unresolved controversy over the roles played by Bayer scientists in the development of aspirin. Arthur Eichengrün, a Bayer chemist, said he was the first to discover an aspirin formulation that did not have the unpleasant side effects of nausea and gastric pain. He also said he had invented the name aspirin and was the first person to use the new formulation to test its safety and efficacy. Bayer contends that aspirin was discovered by Felix Hoffmann to help his father, who had arthritis. Various sources support the conflicting claims. Most mainstream historians attribute the invention of aspirin to Hoffmann and/or Eichengrün. Heroin Heroin (diacetylmorphine), now illegal as an addictive drug, was introduced as a non-addictive substitute for morphine, and trademarked and marketed by Bayer from 1898 to 1910 as a cough suppressant and over-the-counter treatment for other common ailments, including pneumonia and tuberculosis. While Bayer scientists were not the first to make heroin, the company did lead the way in commercializing it. Heroin was a Bayer trademark until after World War I. Bayer's director of pharmacology did not want the drug to have "too complicated a name" so Bayer settled on heroisch, the German word for heroic. Phenobarbital In 1903, Bayer licensed the patent for the hypnotic drug diethylbarbituric acid from its inventors Emil Fischer and Joseph von Mering. It was marketed under the trade name Veronal as a sleep aid beginning in 1904. Systematic investigations of the effect of structural changes on potency and duration of action at Bayer led to the discovery of phenobarbital in 1911 and the discovery of its potent anti-epileptic activity in 1912. Phenobarbital was among the most widely used drugs for the treatment of epilepsy through the 1970s, and as of 2014 it remains on the World Health Organization's list of essential medications. World War I During World War I (1914–1918), Bayer's assets, including the rights to its name and trademarks, were confisca.... Discover the Bayer Ag popular books. Find the top 100 most popular Bayer Ag books.

Best Seller Bayer Ag Books of 2024

  • Meyers v. Bayer Ag synopsis, comments

    Meyers v. Bayer Ag

    Supreme Court of Wyoming

    1 The defendants, Bayer AG, et al. (collectively "Bayer"), seek review of a published court of appeals decision reversing a circuit court order that dismissed all claims brought un...

  • Tracking the Green Molecules synopsis, comments

    Tracking the Green Molecules

    Bayer AG

    Bringing textbooks to life: Bayer AG has developed an innovative scientific teaching service for the iPad. Interactive animations, infographics, video excursions and photo gallerie...

  • The Bayer AG - How Knowledge Drives Success synopsis, comments

    The Bayer AG - How Knowledge Drives Success

    Christine Rackey-Hocke

    Every day we are faced with an increasing amount of information and it is becoming more and more difficult to find the really important parts. And all this in a time in which decis...

  • In re Bayer Ag synopsis, comments

    In re Bayer Ag

    Third Circuit U.S. Court Of Appeals

    (D.C. No. 96cv05650) Argued September 26, 1997 Filed June 9, 1998 OPINION OF THE COURT The promulgation of the Federal Rules of Civil Procedure, with their emphasis on securing ""t...

  • Bayer Ag v. Betachem Inc. synopsis, comments

    Bayer Ag v. Betachem Inc.

    Third Circuit U.S. Court Of Appeals

    ARGUED JANUARY 15, 1999 Filed April 12, 1999 OPINION OF THE COURT Bayer AG appeals the District Court's denial of its motion seeking unredacted documents under 28 U.S.C. § 1782. Ba...

  • Bayer Ag v. Biovail Corporation synopsis, comments

    Bayer Ag v. Biovail Corporation

    Federal Circuit U.S. Court of Appeals

    Appealed from: U.S. District Court for the Northern District of Georgia Senior Judge William C. O'Kelley Bayer brought two separate actions in the United States District Court for ...

  • Bayer Ag v. Elan Pharmaceutical Research Corp. synopsis, comments

    Bayer Ag v. Elan Pharmaceutical Research Corp.

    Federal Circuit U.S. Court of Appeals

    The Mead Corporation ("Mead") appeals from the judgment of the United States District Court for the Northern District of Georgia, holding that Mead infringed claims 1 and 13 of U.S...